Drugs / ACH15
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01702675 | May 2015 → Apr 2017 | — | Ache Laboratorios Farmaceuticos S.A. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACH15 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01702675 ↗ |
| Route | Oral | “ACH15 50mg capsule by mouth single dose (Group 1)” NCT01702675 ↗ |